Archives
L-Glutathione Reduced in GOT1 Redox Assays
2026-09-17
Use L-Glutathione Reduced as a controlled thiol reagent to separate redox rescue from GOT1-driven metabolic effects in pancreatic cancer models. Its aqueous solubility, fresh-solution workflow, and GST compatibility also support reproducible enzyme, affinity, and oxidative-stress experiments.
EdU Flow Cytometry Assay Kits (Cy3): S-Phase Workflows
2026-09-17
EdU Flow Cytometry Assay Kits (Cy3) provide a direct S-phase readout for cancer biology, pharmacodynamic studies, and genotoxicity testing without DNA denaturation. This guide translates TK1-focused endometrial cancer findings into practical assay design, controls, optimization steps, and troubleshooting strategies.
WDR36, Glycolysis, and Human Trophectoderm Fate
2026-09-16
The reference study identifies WDR36 as a regulator of trophectoderm differentiation in human blastoid models and connects its activity to glycolytic metabolism through LDHA. By combining mouse embryo experiments with human stem cell-derived blastoids, transcriptomics, targeted metabolomics, and protein-interaction analysis, the work provides a mechanistic framework for understanding early developmental arrest.
Tobramycin: Mechanism, Evidence, and Lab Use
2026-09-16
Tobramycin is an aminoglycoside antibiotic and bacterial protein synthesis inhibitor used in microbiology research. Its 30S-ribosome activity, defined product specifications, and comparative susceptibility evidence support controlled studies of antibacterial mechanisms and antibiotic resistance.
Penicillin G Sodium: Research Workflows
2026-09-15
Build reproducible Gram-positive challenge assays with Penicillin G Sodium, from aqueous stock preparation through MIC, time-kill, and barrier-model validation. The workflow separates true cell-wall-targeted activity from strain-specific resistance, compound instability, and experimental contamination.
Kanamycin Sulfate in circRNA Workflows
2026-09-15
Kanamycin Sulfate provides dependable bacterial selection upstream of plasmid preparation, while ultrafiltration addresses the separate challenge of enriching circular RNA. This workflow guide connects antibiotic selection, circRNA production, membrane choice, and troubleshooting without treating kanamycin as a direct RNA purification reagent.
L-Alanyl-L-Glutamine: Protocol and QC Guide
2026-09-14
L-Alanyl-L-Glutamine (SKU B8228) provides a defined, water-soluble L-Ala-L-Gln dipeptide for aqueous gastrointestinal, epithelial-barrier, and nutritional workflow development. This guide covers dissolution, handling, QC, and study controls; it should not be treated as evidence of a validated dose, clinical benefit, or compatibility with DMSO or ethanol systems.
GW 6471 as a Causal Probe of PPARα Signaling
2026-09-14
GW 6471 is a PPARα antagonist for testing whether receptor activity causally drives lipid and liver phenotypes. This article develops an evidence-aware assay framework that connects pharmacological inhibition with transcriptomics, pathology, and genetic validation in PFHxS and related models.
AM 281: Decoding CB1–GLT-1 Assay Logic
2026-09-13
AM 281 is a selective CB1 cannabinoid receptor antagonist and inverse agonist for dissecting receptor-to-transporter signaling. This article develops an assay-centered framework linking CB1 pharmacology, astrocytic GLT-1, cognitive phenotypes, and the limitations of translating TBI findings into addiction research.
Pulmonary Arterial Remodeling and RV Afterload
2026-09-12
The reference study combines subject-specific one-dimensional fluid–structure interaction modeling with hemodynamic measurements, tissue mechanics, histology, and x-ray micro-tomography to separate how pulmonary arterial remodeling increases right ventricular afterload. Its central finding is that increased distal resistance most strongly raises maximum main pulmonary artery pressure, whereas reduced arterial compliance substantially alters characteristic impedance.
CD163+ Macrophages and Granulosa Cell Apoptosis in PCOS
2026-09-11
Ye et al. connect macrophage-associated CD163 signaling with granulosa cell injury in polycystic ovary syndrome (PCOS) using transcriptomic analysis, patient serum measurements, a DHEA-induced mouse model, and macrophage–granulosa cell co-culture. The study supports a model in which inflammatory macrophage activity and soluble CD163 accompany granulosa cell apoptosis, while also defining important limits for interpreting CD163 as a causal therapeutic target.
Panobinostat (LBH589) Workflow Guide
2026-09-11
Build more informative HDAC-inhibitor experiments with Panobinostat (LBH589), from epigenetic target engagement to time-resolved cell-death analysis. This workflow separates growth arrest from killing, helping researchers interpret responses in leukemia, multiple myeloma, and aromatase inhibitor-resistant breast cancer models.
Nullscript: From HDAC Mechanism to Translation
2026-09-10
Nullscript offers a mechanistic tool for separating HDAC blockade from transcriptional facilitation. This article connects its cardiac ischemia/reperfusion evidence with emerging placental nanoplastic biology and outlines a disciplined path from assay validation to translational hypothesis testing.
HyperScribe T7 High Yield RNA Synthesis Kit Plus
2026-09-10
Build high-output RNA workflows for FLCN mRNA rescue, labeled hybridization probes, antisense RNA production, and other functional assays. The kit combines up to 180 μg RNA per 20 μL reaction with flexible nucleotide choices and a practical troubleshooting path from template design to purified transcript.
Small Molecule Inhibitor for CK2 and ERK8 Assays
2026-09-09
Use the CK2 and ERK8 inhibitor as a controlled perturbation tool for kinase signaling, protein-interaction assays, and exploratory phase-separation workflows. This guide emphasizes assay design, DMSO handling, orthogonal controls, and the limits of translating kinase inhibition into antiviral research.
3801 records 8/254 page Previous Next First page 上5页 678910 下5页 Last page